top of page

About Timber Pharmaceuticals


We are continuing to pursue opportunities to license and acquire additional late stage assets and are dedicated to collaborating with companies, academia, patient advocacy groups and other industry stakeholders worldwide. If you are interested in a partnership with Timber, please contact us at

 For patients needing more information on CI, please contact: 

bottom of page